Keywords: UCB, Cimzia, PDL BioPharma, Gilead, Natco, Tamiflu, Patent settlement, Generic filing

UCB and PDL settle patent disputes over Cimzia; Natco challenges Gilead’s Tamiflu

Article | 08 February 2011

Brussels, Belgium-based UCB SA (Euronext Brussels: UCB) has entered into a definitive settlement agreement with US firm PDL BioPharma (Nasdaq: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

UCB

PDL BioPharma

Gilead Sciences

Natco Pharma

Go to company listing

Related Drugs

Tamiflu

Cimzia

Go to drug listing